Inaba Yoshitaka, Arai Yasuaki, Sone Miyuki, Aramaki Takeshi, Osuga Keigo, Tanaka Hayao, Kanemasa Kenichi
Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Department of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Cardiovasc Intervent Radiol. 2017 Dec;40(12):1921-1926. doi: 10.1007/s00270-017-1789-8. Epub 2017 Sep 6.
Sumitomo Bakelite has developed a steerable microcatheter with a mechanism on the handle for changing the direction of the catheter tip. Experiments were conducted in an animal model to evaluate the practicality of the catheter with the goal of introduction into clinical use.
The steerable microcatheter has the following specifications: external diameter 2.4F/2.9F (distal/proximal portion); internal diameter 0.021 inches; effective length 125 cm; and it is fitted with a dial on the proximal portion for moving the tip. Five interventional radiologists evaluated the microcatheter in animal experiments using piglets. The test catheter was compared with commercial straight microcatheters based on procedure time required to insert the catheter into two prescribed patterns of arterial branching (P-1: hepatic artery, P-2: iliac artery), fluoroscopy time, amount of contrast agent used, and frequency of guidewire use. Furthermore, the renal arteries into which each catheter was inserted were excised and examined for the extent of vascular damage.
Compared to the commercial products, the steerable microcatheter used without a guidewire required shorter procedure time (43.0/75.2% reductions in P-1/P-2), fluoroscopy time tended to be shorter (5.1/74.1% reductions), and the amount of contrast agent used tended to be lower (38.2/52.3% reductions). No damage was seen to the luminal surface of the renal arteries traversed by either microcatheter. During the experiment, there were no problems or defects with either microcatheter while intravascular procedure.
These animal experiments confirmed that the steerable microcatheter had the functionality required for its development as a commercial medical device.
住友电木公司开发了一种可操纵的微导管,其手柄上设有用于改变导管尖端方向的机构。在动物模型中进行了实验,以评估该导管引入临床使用的实用性。
可操纵微导管具有以下规格:外径2.4F/2.9F(远端/近端部分);内径0.021英寸;有效长度125厘米;近端部分装有一个用于移动尖端的刻度盘。五位介入放射科医生在使用仔猪的动物实验中对微导管进行了评估。将测试导管与商用直微导管在将导管插入两种规定的动脉分支模式(P-1:肝动脉,P-2:髂动脉)所需的操作时间、透视时间、造影剂用量以及导丝使用频率方面进行了比较。此外,将插入各导管的肾动脉切除并检查血管损伤程度。
与商用产品相比,无需导丝使用的可操纵微导管所需操作时间更短(P-1/P-2分别减少43.0/75.2%),透视时间往往更短(减少5.1/74.1%),造影剂用量往往更低(减少38.2/52.3%)。两种微导管穿过的肾动脉管腔表面均未见损伤。在实验过程中,两种微导管在血管内操作时均未出现问题或缺陷。
这些动物实验证实,可操纵微导管具有作为商用医疗设备开发所需的功能。